A detailed history of Alta Advisers LTD transactions in Amgen Inc stock. As of the latest transaction made, Alta Advisers LTD holds 1,453 shares of AMGN stock, worth $397,264. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,453
Previous 1,400 3.79%
Holding current value
$397,264
Previous $437,000 7.09%
% of portfolio
0.22%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $16,397 - $17,881
53 Added 3.79%
1,453 $468,000
Q3 2022

Oct 28, 2022

BUY
$224.46 - $253.15 $314,244 - $354,410
1,400 New
1,400 $316,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alta Advisers LTD Portfolio

Follow Alta Advisers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Advisers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Alta Advisers LTD with notifications on news.